MannKind
(NASDAQ:MNKD)
$4.41
0[0.00%]
Last update: 12:26PM Get Real Time Here
Q1 2024 Earnings were released on Wed May 8th, after the market close
The most recent conference call was at 17:00 PM, 6 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

MannKind Stock (NASDAQ:MNKD), Quotes and News Summary

MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.

Open$4.460
Close-
Volume / Avg.551.594K / 2.916M
Day Range4.400 - 4.501
52 Wk Range3.170 - 5.750
Market Cap$1.201B
P/E Ratio110.250
Dividend Yield-
ExchangeNASDAQ
RSI
55
Short Interest
11.55%
Days to Cover12.8

Recent News

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Avi Kapoor
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.
Avi Kapoor
What's Going On With MannKind Stock?
MannKind Corporation shares are trending on social media Monday. CNBC's Jim Cramer mentioned the stock on the "Mad Money Lightning Round" Friday. The stock has been "hanging out there forever, and it's finally starting to look like it's going to have an earnings breakout, but I am one of those people who's jaundiced about it. I got to wait to see if they come up with something," Cramer said.
Erica Kollmann
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
1
Feb
1
Mar
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MNKD
GYRE

FAQ

Q

How do I buy MannKind (MNKD) stock?

A

You can purchase shares of MannKind (NASDAQ: MNKD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are MannKind's (MNKD) competitors?

A

Other companies in MannKind’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA), Immatics (NASDAQ:IMTX) and Prothena Corp (NASDAQ:PRTA).

Q

What is the target price for MannKind (MNKD) stock?

A

The latest price target for MannKind (NASDAQ: MNKD) was reported by Cantor Fitzgerald on Thursday, May 9, 2024. The analyst firm set a price target for 6.50 expecting MNKD to rise to within 12 months (a possible 47.39% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for MannKind (MNKD)?

A

The stock price for MannKind (NASDAQ: MNKD) is $4.41 last updated Today at May 14, 2024 at 12:26 PM EDT.

Q

Does MannKind (MNKD) pay a dividend?

A

There are no upcoming dividends for MannKind.

Q

When is MannKind (NASDAQ:MNKD) reporting earnings?

A

MannKind’s Q2 earnings are confirmed for Monday, August 5, 2024.

Q

Is MannKind (MNKD) going to split?

A

There is no upcoming split for MannKind.

Q

What sector and industry does MannKind (MNKD) operate in?

A

MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch